Review



c src y416  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Cell Signaling Technology Inc c src y416
    Cav1 tyrosine (Y)-14 phosphorylation induced by APC–PAR1 is mediated by c-Src. A – C, endothelial EA.hy926 cells were pretreated with dasatinib or DMSO prior to addition of APC. Cell lysates were then immunoblotted to detect Cav1 Y14 and c-Src <t>Y416</t> phosphorylation as indicated. D – G, endothelial cells transfected with nonspecific (NS) or c-Src-specific siRNA were treated with or without APC, lysed, and immunoblotted as indicated. β-tubulin and GAPDH were used as loading controls. The data were quantified (mean ± SD) from four independent biological replicates and expressed as the fraction relative to the untreated control and analyzed by two-way ANOVA followed by Šídák's multiple comparisons test. ( B ) ∗ p = 0.0136; ( C ) ∗∗ p = 0.0038; ( F ) ∗∗∗ p = 0.0003; and ( G ) ∗ p = 0.0125. Student's unpaired t test, ( E ) ∗∗∗ p = 0.0002. APC, activated protein C; Cav1, caveolin-1; DMSO, dimethyl sulfoxide; PAR1, protease-activated receptor 1.
    C Src Y416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 2358 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+src/Phospho-Src+Family+(Tyr416)+Antibody/pmc12925215-265-32-34
    Average 96 stars, based on 2358 article reviews
    c src y416 - by Bioz Stars, 2026-10
    96/100 stars

    Images

    1) Product Images from "Activated protein C drives β-arrestin-2- and c-Src-dependent phosphorylation of Cav1 and modulates Cav1 association with PAR1 and GRK5"

    Article Title: Activated protein C drives β-arrestin-2- and c-Src-dependent phosphorylation of Cav1 and modulates Cav1 association with PAR1 and GRK5

    Journal: The Journal of Biological Chemistry

    doi: 10.1016/j.jbc.2026.111190

    Cav1 tyrosine (Y)-14 phosphorylation induced by APC–PAR1 is mediated by c-Src. A – C, endothelial EA.hy926 cells were pretreated with dasatinib or DMSO prior to addition of APC. Cell lysates were then immunoblotted to detect Cav1 Y14 and c-Src Y416 phosphorylation as indicated. D – G, endothelial cells transfected with nonspecific (NS) or c-Src-specific siRNA were treated with or without APC, lysed, and immunoblotted as indicated. β-tubulin and GAPDH were used as loading controls. The data were quantified (mean ± SD) from four independent biological replicates and expressed as the fraction relative to the untreated control and analyzed by two-way ANOVA followed by Šídák's multiple comparisons test. ( B ) ∗ p = 0.0136; ( C ) ∗∗ p = 0.0038; ( F ) ∗∗∗ p = 0.0003; and ( G ) ∗ p = 0.0125. Student's unpaired t test, ( E ) ∗∗∗ p = 0.0002. APC, activated protein C; Cav1, caveolin-1; DMSO, dimethyl sulfoxide; PAR1, protease-activated receptor 1.
    Figure Legend Snippet: Cav1 tyrosine (Y)-14 phosphorylation induced by APC–PAR1 is mediated by c-Src. A – C, endothelial EA.hy926 cells were pretreated with dasatinib or DMSO prior to addition of APC. Cell lysates were then immunoblotted to detect Cav1 Y14 and c-Src Y416 phosphorylation as indicated. D – G, endothelial cells transfected with nonspecific (NS) or c-Src-specific siRNA were treated with or without APC, lysed, and immunoblotted as indicated. β-tubulin and GAPDH were used as loading controls. The data were quantified (mean ± SD) from four independent biological replicates and expressed as the fraction relative to the untreated control and analyzed by two-way ANOVA followed by Šídák's multiple comparisons test. ( B ) ∗ p = 0.0136; ( C ) ∗∗ p = 0.0038; ( F ) ∗∗∗ p = 0.0003; and ( G ) ∗ p = 0.0125. Student's unpaired t test, ( E ) ∗∗∗ p = 0.0002. APC, activated protein C; Cav1, caveolin-1; DMSO, dimethyl sulfoxide; PAR1, protease-activated receptor 1.

    Techniques Used: Phospho-proteomics, Transfection, Control

    βarr2 is required for APC-stimulated c-Src tyrosine (Y)-416 phosphorylation and Cav1 Y14 phosphorylation. Endothelial EA.hy926 cells were transfected with nonspecific (NS) or βarr2-specific siRNA, treated with APC, and c-Src Y416 phosphorylation ( A and B ) and Cav1 Y14 phosphorylation ( C and D ) were detected by immunoblotting as indicated. GAPDH was used as a loading control. The data were quantified (mean ± SD) from four independent biological replicates and expressed as the fraction relative to the untreated control and analyzed by two-way ANOVA followed by Šídák's multiple comparisons test. B, NS siRNA with and without APC, ∗∗ p = 0.0097; ns = not significant. D, NS siRNA with and without APC ∗∗∗ p = 0.0009; βarr2 siRNA with and without APC, ∗∗ p = 0.0061. APC, activated protein C; βarr2, β-arrestin-2; Cav1, caveolin-1.
    Figure Legend Snippet: βarr2 is required for APC-stimulated c-Src tyrosine (Y)-416 phosphorylation and Cav1 Y14 phosphorylation. Endothelial EA.hy926 cells were transfected with nonspecific (NS) or βarr2-specific siRNA, treated with APC, and c-Src Y416 phosphorylation ( A and B ) and Cav1 Y14 phosphorylation ( C and D ) were detected by immunoblotting as indicated. GAPDH was used as a loading control. The data were quantified (mean ± SD) from four independent biological replicates and expressed as the fraction relative to the untreated control and analyzed by two-way ANOVA followed by Šídák's multiple comparisons test. B, NS siRNA with and without APC, ∗∗ p = 0.0097; ns = not significant. D, NS siRNA with and without APC ∗∗∗ p = 0.0009; βarr2 siRNA with and without APC, ∗∗ p = 0.0061. APC, activated protein C; βarr2, β-arrestin-2; Cav1, caveolin-1.

    Techniques Used: Phospho-proteomics, Transfection, Western Blot, Control

    Model of PAR1–GRK5–βarr2–c-Src regulation by Cav1. A substantial population of PAR1–Cav1 and GRK5–Cav1 complexes coexist at the plasma membrane under basal conditions. APC bound to EPCR cleaves and activates PAR1, resulting in GRK5-dependent phosphorylation of the receptor C-terminal tail within 30 min. This may occur during a time when GRK5 dissociates from Cav1. Next, APC-activated and phosphorylated PAR1 recruits βarr2, which promotes activation of c-Src Y416 phosphorylation and c-Src-dependent Cav1 Y14 phosphorylation, a process that occurs after 30 min and is sustained through 90 min. At 30 min, GRK5–Cav1 may reassociate, whereas activated PAR1 and Y14 phosphorylated Cav1 remain dissociated through the 90 min interval. APC, activated protein C; βarr2, βarr2; Cav1, caveolin-1; EPCR, endothelial protein C receptor; GRK5, GPCR kinase 5; PAR1, protease-activated receptor-1.
    Figure Legend Snippet: Model of PAR1–GRK5–βarr2–c-Src regulation by Cav1. A substantial population of PAR1–Cav1 and GRK5–Cav1 complexes coexist at the plasma membrane under basal conditions. APC bound to EPCR cleaves and activates PAR1, resulting in GRK5-dependent phosphorylation of the receptor C-terminal tail within 30 min. This may occur during a time when GRK5 dissociates from Cav1. Next, APC-activated and phosphorylated PAR1 recruits βarr2, which promotes activation of c-Src Y416 phosphorylation and c-Src-dependent Cav1 Y14 phosphorylation, a process that occurs after 30 min and is sustained through 90 min. At 30 min, GRK5–Cav1 may reassociate, whereas activated PAR1 and Y14 phosphorylated Cav1 remain dissociated through the 90 min interval. APC, activated protein C; βarr2, βarr2; Cav1, caveolin-1; EPCR, endothelial protein C receptor; GRK5, GPCR kinase 5; PAR1, protease-activated receptor-1.

    Techniques Used: Clinical Proteomics, Membrane, Phospho-proteomics, Activation Assay

    Related Articles

    Membrane:

    Article Title: Role of Src family kinases Fyn and Lyn in arenavirus infection.
    Article Snippet: .. The membrane was stained with the primary antibodies Phospho-Src Family Tyr416 (Cell Signaling Technology; dilution 1:1,000) or Src Rabbit mAb (Cell Signaling Technology; dilution 1:1,000). .. Densitometry analysis was performed using ImageJ over three independent experiments. siRNA-mediated gene knockdown Stock solutions (50 nM per well in 24-well plates) of siRNA listed in Table S1 (Gene Pharma) and siRNA control (named NC, UUC UCC GAA CGU GUC ACG UTT) were prepared using RNase-free water. siRNA transfection was performed with RNAiMAX (Invitrogen) according to instructions; the siRNA used in per well was at a final concen tration of 5 pmol.

    Article Title: Compositions and methods for increasing cancer cell sensitivity to alternating electric fields
    Article Snippet: Samples were run on SDS-polyacrylamide gel electrophoresis (Bolt 8% Bis-Tris base gel NW00080BOX, Thermo-Fischer). .. After electrophoresis, proteins were transferred to 0.2 μm polyvinylidene difluoride membrane (Immuno-Blot PVDF #162-0177, Bio-Rad) and probed with the appropriate primary antibody: GAPDH (SC-32233, Santa Cruz), Vinculin (ab140007, Abcam), Cyclin D1 (2922, Cell Signaling), Rb (9309, Cell Signaling), pRb S807/811 (8516, Cell Signaling), pAkt 5473, (4051, Cell signaling), Akt (2920, Cell signaling)), FAK (3283S, Cell signaling), Phospho-FAK (Tyr397) (3283S, Cell signaling, Src (2109S, cell signaling) and Phospho-Src (Tyr416) (2101S, Cell signaling). followed by horseradish peroxidase-conjugated secondary antibody (goat anti rabbit 7074, Cell Signaling and goat anti mouse 7076, Cell Signaling) and a chemiluminescent substrate (WBLUF0100, Signa-Aldrich). ..

    Staining:

    Article Title: Role of Src family kinases Fyn and Lyn in arenavirus infection.
    Article Snippet: .. The membrane was stained with the primary antibodies Phospho-Src Family Tyr416 (Cell Signaling Technology; dilution 1:1,000) or Src Rabbit mAb (Cell Signaling Technology; dilution 1:1,000). .. Densitometry analysis was performed using ImageJ over three independent experiments. siRNA-mediated gene knockdown Stock solutions (50 nM per well in 24-well plates) of siRNA listed in Table S1 (Gene Pharma) and siRNA control (named NC, UUC UCC GAA CGU GUC ACG UTT) were prepared using RNase-free water. siRNA transfection was performed with RNAiMAX (Invitrogen) according to instructions; the siRNA used in per well was at a final concen tration of 5 pmol.

    Electrophoresis:

    Article Title: Compositions and methods for increasing cancer cell sensitivity to alternating electric fields
    Article Snippet: Samples were run on SDS-polyacrylamide gel electrophoresis (Bolt 8% Bis-Tris base gel NW00080BOX, Thermo-Fischer). .. After electrophoresis, proteins were transferred to 0.2 μm polyvinylidene difluoride membrane (Immuno-Blot PVDF #162-0177, Bio-Rad) and probed with the appropriate primary antibody: GAPDH (SC-32233, Santa Cruz), Vinculin (ab140007, Abcam), Cyclin D1 (2922, Cell Signaling), Rb (9309, Cell Signaling), pRb S807/811 (8516, Cell Signaling), pAkt 5473, (4051, Cell signaling), Akt (2920, Cell signaling)), FAK (3283S, Cell signaling), Phospho-FAK (Tyr397) (3283S, Cell signaling, Src (2109S, cell signaling) and Phospho-Src (Tyr416) (2101S, Cell signaling). followed by horseradish peroxidase-conjugated secondary antibody (goat anti rabbit 7074, Cell Signaling and goat anti mouse 7076, Cell Signaling) and a chemiluminescent substrate (WBLUF0100, Signa-Aldrich). ..

    Incubation:

    Article Title: Rabdosin B suppresses proliferation of nonsmall cell lung cancer by regulating the SRC/PI3K/AKT signaling pathway.
    Article Snippet: .. Membranes were then blocked with 5% skim milk for 2 h at room temperature, and incubated with following primary antibodies at 4 °C overnight: PI3K (1:1000, #4292, CST), p-PI3K (1:1000, #17366, CST), Akt (1:1000, #9272, CST), p-Akt (1:2000, #4060, CST), SRC (1:1000, #2108, CST), p-SRC (1:1000, #2101, CST), Bax (1:1000, #2772, CST), Bcl-2 (1:5000, ET1702-53, HuaBio), cleaved caspase-3 (1:1000, ET1602-47, HuaBio), cleaved caspase-9 (1:1000, T40046, Abmart), MMP2 (1:1000, 10373-2-AP, Proteintech), MMP9 (1:2000, 10375-2-AP, Proteintech), GAPDH (1:1000, AB-P-R001, Goodhere Biotech). .. After washed with TBST buffer, each membrane was incubated for 2h at room temperature with HRP-conjugated secondary antibody (1:10000, #410406, Biolegend).

    Article Title: Rabdosin B suppresses proliferation of nonsmall cell lung cancer by regulating the SRC/PI3K/AKT signaling pathway
    Article Snippet: .. Membranes were then blocked with 5% skim milk for 2 h at room temperature, and incubated with following primary antibodies at 4 °C overnight: PI3K (1:1000, #4292, CST), p-PI3K (1:1000, #17366, CST), Akt (1:1000, #9272, CST), p-Akt (1:2000, #4060, CST), SRC (1:1000, #2108, CST), p-SRC (1:1000, #2101, CST), Bax (1:1000, #2772, CST), Bcl-2 (1:5000, ET1702-53, HuaBio), cleaved caspase-3 (1:1000, ET1602-47, HuaBio), cleaved caspase-9 (1:1000, T40046 , Abmart), MMP2 (1:1000, 10373-2-AP, Proteintech), MMP9 (1:2000, 10375-2-AP, Proteintech), GAPDH (1:1000, AB-P-R001, Goodhere Biotech). .. After washed with TBST buffer, each membrane was incubated for 2h at room temperature with HRP-conjugated secondary antibody (1:10000, #410406, Biolegend).

    other:

    Article Title: Spatiotemporal dynamics of β-arrestin-mediated Src activation in 5-HT7 receptor signaling pathway.
    Article Snippet: Antibodies against ERK (#4695), p-Tyr202/Tyr204 ERK (#9101), Src (#2108) and p-Tyr416 Src (#2101) were purchased from Cell signaling technology.

    Article Title: Extracellular matrix rigidity controls breast cancer metastasis via TYK2-mediated mechanotransduction.
    Article Snippet: Antibodies were conjugated to protein G beads (LYN) or protein A beads (TYK2) (Invitrogen), crosslinked using disuccinimidyl suberate (Pierce) as per manufacturer’s protocol, incubated with lysates overnight at 4°C, washed eight times with IP lysis buffer supplemented with 200 mM NaCl, and eluted by incubation in LDS sample buffer with 50 mM DTT at 70°C for 10 minutes.



    Similar Products

    97
    Santa Cruz Biotechnology src targeting sirna sc 5266
    Src Targeting Sirna Sc 5266, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+src/c-Src+Antibody/pmc13046926-253-2-8
    Average 97 stars, based on 1 article reviews
    src targeting sirna sc 5266 - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    97
    Santa Cruz Biotechnology anti src primary antibody
    Anti Src Primary Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+src/c-Src+Antibody/pm41872167-236-0-6
    Average 97 stars, based on 1 article reviews
    anti src primary antibody - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc phospho c src tyr416 d49g4 cell signaling technology
    Phospho C Src Tyr416 D49g4 Cell Signaling Technology, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+src/10__3390_slash_cancers18071082-84-3-6
    Average 86 stars, based on 1 article reviews
    phospho c src tyr416 d49g4 cell signaling technology - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc c src family phospho tyr416
    C Src Family Phospho Tyr416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+src/Phospho-Src+Family+(Tyr416)+Rabbit+mAb/pm41871717-58-48-63
    Average 96 stars, based on 1 article reviews
    c src family phospho tyr416 - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    94
    ABclonal Biotechnology c src
    C Src, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+src/%5BKO+Validated%5D+Src+Rabbit+mAb/pm41825701-62-38-61
    Average 94 stars, based on 1 article reviews
    c src - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc c src y416
    Cav1 tyrosine (Y)-14 phosphorylation induced by APC–PAR1 is mediated by c-Src. A – C, endothelial EA.hy926 cells were pretreated with dasatinib or DMSO prior to addition of APC. Cell lysates were then immunoblotted to detect Cav1 Y14 and c-Src <t>Y416</t> phosphorylation as indicated. D – G, endothelial cells transfected with nonspecific (NS) or c-Src-specific siRNA were treated with or without APC, lysed, and immunoblotted as indicated. β-tubulin and GAPDH were used as loading controls. The data were quantified (mean ± SD) from four independent biological replicates and expressed as the fraction relative to the untreated control and analyzed by two-way ANOVA followed by Šídák's multiple comparisons test. ( B ) ∗ p = 0.0136; ( C ) ∗∗ p = 0.0038; ( F ) ∗∗∗ p = 0.0003; and ( G ) ∗ p = 0.0125. Student's unpaired t test, ( E ) ∗∗∗ p = 0.0002. APC, activated protein C; Cav1, caveolin-1; DMSO, dimethyl sulfoxide; PAR1, protease-activated receptor 1.
    C Src Y416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+src/Phospho-Src+Family+(Tyr416)+Antibody/pmc12925215-265-32-34
    Average 96 stars, based on 1 article reviews
    c src y416 - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc anti c src
    Cav1 tyrosine (Y)-14 phosphorylation induced by APC–PAR1 is mediated by c-Src. A – C, endothelial EA.hy926 cells were pretreated with dasatinib or DMSO prior to addition of APC. Cell lysates were then immunoblotted to detect Cav1 Y14 and c-Src <t>Y416</t> phosphorylation as indicated. D – G, endothelial cells transfected with nonspecific (NS) or c-Src-specific siRNA were treated with or without APC, lysed, and immunoblotted as indicated. β-tubulin and GAPDH were used as loading controls. The data were quantified (mean ± SD) from four independent biological replicates and expressed as the fraction relative to the untreated control and analyzed by two-way ANOVA followed by Šídák's multiple comparisons test. ( B ) ∗ p = 0.0136; ( C ) ∗∗ p = 0.0038; ( F ) ∗∗∗ p = 0.0003; and ( G ) ∗ p = 0.0125. Student's unpaired t test, ( E ) ∗∗∗ p = 0.0002. APC, activated protein C; Cav1, caveolin-1; DMSO, dimethyl sulfoxide; PAR1, protease-activated receptor 1.
    Anti C Src, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+src/pmc12925215-265-36-37
    Average 86 stars, based on 1 article reviews
    anti c src - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    93
    Proteintech src
    Experimental validation. ( A , C , E , G , I and K ) Relative expression of <t>SRC,</t> <t>ESR1,</t> EGFR, PTGS2, PPARG and HSP90AA1 via RT-qPCR. ( B , D , F , H , J and L ) Typical pictures and scores of the relative expression of SRC, ESR1, EGFR, PTGS2, PPARG and HSP90AA1 via IHC; 20×, Scale bar: 100 μm; 40×, Scale bar: 50 μm. ** P < 0.01, and *** P < 0.001
    Src, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+src/c-SRC+Antibody/pmc13040831-99-19-15
    Average 93 stars, based on 1 article reviews
    src - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    97
    Santa Cruz Biotechnology fitc anti src antibody
    Experimental validation. ( A , C , E , G , I and K ) Relative expression of <t>SRC,</t> <t>ESR1,</t> EGFR, PTGS2, PPARG and HSP90AA1 via RT-qPCR. ( B , D , F , H , J and L ) Typical pictures and scores of the relative expression of SRC, ESR1, EGFR, PTGS2, PPARG and HSP90AA1 via IHC; 20×, Scale bar: 100 μm; 40×, Scale bar: 50 μm. ** P < 0.01, and *** P < 0.001
    Fitc Anti Src Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+src/c-Src+Antibody/pm41732084-66-11-13
    Average 97 stars, based on 1 article reviews
    fitc anti src antibody - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    Image Search Results


    Cav1 tyrosine (Y)-14 phosphorylation induced by APC–PAR1 is mediated by c-Src. A – C, endothelial EA.hy926 cells were pretreated with dasatinib or DMSO prior to addition of APC. Cell lysates were then immunoblotted to detect Cav1 Y14 and c-Src Y416 phosphorylation as indicated. D – G, endothelial cells transfected with nonspecific (NS) or c-Src-specific siRNA were treated with or without APC, lysed, and immunoblotted as indicated. β-tubulin and GAPDH were used as loading controls. The data were quantified (mean ± SD) from four independent biological replicates and expressed as the fraction relative to the untreated control and analyzed by two-way ANOVA followed by Šídák's multiple comparisons test. ( B ) ∗ p = 0.0136; ( C ) ∗∗ p = 0.0038; ( F ) ∗∗∗ p = 0.0003; and ( G ) ∗ p = 0.0125. Student's unpaired t test, ( E ) ∗∗∗ p = 0.0002. APC, activated protein C; Cav1, caveolin-1; DMSO, dimethyl sulfoxide; PAR1, protease-activated receptor 1.

    Journal: The Journal of Biological Chemistry

    Article Title: Activated protein C drives β-arrestin-2- and c-Src-dependent phosphorylation of Cav1 and modulates Cav1 association with PAR1 and GRK5

    doi: 10.1016/j.jbc.2026.111190

    Figure Lengend Snippet: Cav1 tyrosine (Y)-14 phosphorylation induced by APC–PAR1 is mediated by c-Src. A – C, endothelial EA.hy926 cells were pretreated with dasatinib or DMSO prior to addition of APC. Cell lysates were then immunoblotted to detect Cav1 Y14 and c-Src Y416 phosphorylation as indicated. D – G, endothelial cells transfected with nonspecific (NS) or c-Src-specific siRNA were treated with or without APC, lysed, and immunoblotted as indicated. β-tubulin and GAPDH were used as loading controls. The data were quantified (mean ± SD) from four independent biological replicates and expressed as the fraction relative to the untreated control and analyzed by two-way ANOVA followed by Šídák's multiple comparisons test. ( B ) ∗ p = 0.0136; ( C ) ∗∗ p = 0.0038; ( F ) ∗∗∗ p = 0.0003; and ( G ) ∗ p = 0.0125. Student's unpaired t test, ( E ) ∗∗∗ p = 0.0002. APC, activated protein C; Cav1, caveolin-1; DMSO, dimethyl sulfoxide; PAR1, protease-activated receptor 1.

    Article Snippet: In this study, the following antibodies were used: mouse anti–PAR1 WEDE (Beckman Coulter, #IM2584), anti-Cav1 (CST, #3267S and BD, #610060), anti-Cav1 Y14 phospho antibody (CST, #3251), anti-βarr2 (Abcam, #ab54790), GAPDH (GeneTex, #GT239), c-Src Y416 (CST, #2101), anti-c-Src (CST, #2109), GRK5 (Santa Cruz, #sc-518005), GRK5 polyclonal antibody (Invitrogen, #PA5-96262) anti-GRK4-6 (Millipore, #05-466), anti-HA (CST, #3724S), anti-rabbit IgG (CST, #2729), anti-β-Tubulin (CST, #86298), anti–early endosome antigen-1 (BD Biosciences, #610457), anti-Vinculin (Sigma, #V9131), and anti-HA conjugated to horseradish peroxidase (Roche, #11667475001).

    Techniques: Phospho-proteomics, Transfection, Control

    βarr2 is required for APC-stimulated c-Src tyrosine (Y)-416 phosphorylation and Cav1 Y14 phosphorylation. Endothelial EA.hy926 cells were transfected with nonspecific (NS) or βarr2-specific siRNA, treated with APC, and c-Src Y416 phosphorylation ( A and B ) and Cav1 Y14 phosphorylation ( C and D ) were detected by immunoblotting as indicated. GAPDH was used as a loading control. The data were quantified (mean ± SD) from four independent biological replicates and expressed as the fraction relative to the untreated control and analyzed by two-way ANOVA followed by Šídák's multiple comparisons test. B, NS siRNA with and without APC, ∗∗ p = 0.0097; ns = not significant. D, NS siRNA with and without APC ∗∗∗ p = 0.0009; βarr2 siRNA with and without APC, ∗∗ p = 0.0061. APC, activated protein C; βarr2, β-arrestin-2; Cav1, caveolin-1.

    Journal: The Journal of Biological Chemistry

    Article Title: Activated protein C drives β-arrestin-2- and c-Src-dependent phosphorylation of Cav1 and modulates Cav1 association with PAR1 and GRK5

    doi: 10.1016/j.jbc.2026.111190

    Figure Lengend Snippet: βarr2 is required for APC-stimulated c-Src tyrosine (Y)-416 phosphorylation and Cav1 Y14 phosphorylation. Endothelial EA.hy926 cells were transfected with nonspecific (NS) or βarr2-specific siRNA, treated with APC, and c-Src Y416 phosphorylation ( A and B ) and Cav1 Y14 phosphorylation ( C and D ) were detected by immunoblotting as indicated. GAPDH was used as a loading control. The data were quantified (mean ± SD) from four independent biological replicates and expressed as the fraction relative to the untreated control and analyzed by two-way ANOVA followed by Šídák's multiple comparisons test. B, NS siRNA with and without APC, ∗∗ p = 0.0097; ns = not significant. D, NS siRNA with and without APC ∗∗∗ p = 0.0009; βarr2 siRNA with and without APC, ∗∗ p = 0.0061. APC, activated protein C; βarr2, β-arrestin-2; Cav1, caveolin-1.

    Article Snippet: In this study, the following antibodies were used: mouse anti–PAR1 WEDE (Beckman Coulter, #IM2584), anti-Cav1 (CST, #3267S and BD, #610060), anti-Cav1 Y14 phospho antibody (CST, #3251), anti-βarr2 (Abcam, #ab54790), GAPDH (GeneTex, #GT239), c-Src Y416 (CST, #2101), anti-c-Src (CST, #2109), GRK5 (Santa Cruz, #sc-518005), GRK5 polyclonal antibody (Invitrogen, #PA5-96262) anti-GRK4-6 (Millipore, #05-466), anti-HA (CST, #3724S), anti-rabbit IgG (CST, #2729), anti-β-Tubulin (CST, #86298), anti–early endosome antigen-1 (BD Biosciences, #610457), anti-Vinculin (Sigma, #V9131), and anti-HA conjugated to horseradish peroxidase (Roche, #11667475001).

    Techniques: Phospho-proteomics, Transfection, Western Blot, Control

    Model of PAR1–GRK5–βarr2–c-Src regulation by Cav1. A substantial population of PAR1–Cav1 and GRK5–Cav1 complexes coexist at the plasma membrane under basal conditions. APC bound to EPCR cleaves and activates PAR1, resulting in GRK5-dependent phosphorylation of the receptor C-terminal tail within 30 min. This may occur during a time when GRK5 dissociates from Cav1. Next, APC-activated and phosphorylated PAR1 recruits βarr2, which promotes activation of c-Src Y416 phosphorylation and c-Src-dependent Cav1 Y14 phosphorylation, a process that occurs after 30 min and is sustained through 90 min. At 30 min, GRK5–Cav1 may reassociate, whereas activated PAR1 and Y14 phosphorylated Cav1 remain dissociated through the 90 min interval. APC, activated protein C; βarr2, βarr2; Cav1, caveolin-1; EPCR, endothelial protein C receptor; GRK5, GPCR kinase 5; PAR1, protease-activated receptor-1.

    Journal: The Journal of Biological Chemistry

    Article Title: Activated protein C drives β-arrestin-2- and c-Src-dependent phosphorylation of Cav1 and modulates Cav1 association with PAR1 and GRK5

    doi: 10.1016/j.jbc.2026.111190

    Figure Lengend Snippet: Model of PAR1–GRK5–βarr2–c-Src regulation by Cav1. A substantial population of PAR1–Cav1 and GRK5–Cav1 complexes coexist at the plasma membrane under basal conditions. APC bound to EPCR cleaves and activates PAR1, resulting in GRK5-dependent phosphorylation of the receptor C-terminal tail within 30 min. This may occur during a time when GRK5 dissociates from Cav1. Next, APC-activated and phosphorylated PAR1 recruits βarr2, which promotes activation of c-Src Y416 phosphorylation and c-Src-dependent Cav1 Y14 phosphorylation, a process that occurs after 30 min and is sustained through 90 min. At 30 min, GRK5–Cav1 may reassociate, whereas activated PAR1 and Y14 phosphorylated Cav1 remain dissociated through the 90 min interval. APC, activated protein C; βarr2, βarr2; Cav1, caveolin-1; EPCR, endothelial protein C receptor; GRK5, GPCR kinase 5; PAR1, protease-activated receptor-1.

    Article Snippet: In this study, the following antibodies were used: mouse anti–PAR1 WEDE (Beckman Coulter, #IM2584), anti-Cav1 (CST, #3267S and BD, #610060), anti-Cav1 Y14 phospho antibody (CST, #3251), anti-βarr2 (Abcam, #ab54790), GAPDH (GeneTex, #GT239), c-Src Y416 (CST, #2101), anti-c-Src (CST, #2109), GRK5 (Santa Cruz, #sc-518005), GRK5 polyclonal antibody (Invitrogen, #PA5-96262) anti-GRK4-6 (Millipore, #05-466), anti-HA (CST, #3724S), anti-rabbit IgG (CST, #2729), anti-β-Tubulin (CST, #86298), anti–early endosome antigen-1 (BD Biosciences, #610457), anti-Vinculin (Sigma, #V9131), and anti-HA conjugated to horseradish peroxidase (Roche, #11667475001).

    Techniques: Clinical Proteomics, Membrane, Phospho-proteomics, Activation Assay

    Experimental validation. ( A , C , E , G , I and K ) Relative expression of SRC, ESR1, EGFR, PTGS2, PPARG and HSP90AA1 via RT-qPCR. ( B , D , F , H , J and L ) Typical pictures and scores of the relative expression of SRC, ESR1, EGFR, PTGS2, PPARG and HSP90AA1 via IHC; 20×, Scale bar: 100 μm; 40×, Scale bar: 50 μm. ** P < 0.01, and *** P < 0.001

    Journal: BMC Pharmacology & Toxicology

    Article Title: Investigating the mechanisms by which bisphenol A affects osteoarthritis through a novel network toxicology framework and experimental validation

    doi: 10.1186/s40360-026-01108-0

    Figure Lengend Snippet: Experimental validation. ( A , C , E , G , I and K ) Relative expression of SRC, ESR1, EGFR, PTGS2, PPARG and HSP90AA1 via RT-qPCR. ( B , D , F , H , J and L ) Typical pictures and scores of the relative expression of SRC, ESR1, EGFR, PTGS2, PPARG and HSP90AA1 via IHC; 20×, Scale bar: 100 μm; 40×, Scale bar: 50 μm. ** P < 0.01, and *** P < 0.001

    Article Snippet: The sections were incubated overnight at 4 °C with the following primary antibodies (all from Proteintech, diluted in PBS): SRC (1:200, 60315-1-Ig), ESR1 (1:200, 21244-1-AP), EGFR (1:1000, 18986-1-AP), PTGS2 (1:1000, 66351-1-Ig), PPARG (1:400, 16643-1-AP), and HSP90AA1 (1:400000, 13171-1-AP).

    Techniques: Biomarker Discovery, Expressing, Quantitative RT-PCR